IBRX - CIK 0001326110
ImmunityBio, Inc. has filed 528 documents with the SEC between 2005 and 2026. The most frequent type is insider trade (204 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Major company event | 8-K | 2024-06-12 | 2024-06-11 |
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| EFFECT | - | 2024-05-02 | - |
| Company correspondence | CORRESP | 2024-04-30 | - |
| Proxy materials | DEFA14A | 2024-04-29 | - |
| Proxy statement | DEF 14A | 2024-04-29 | 2024-06-11 |
| Annual report to shareholders | ARS | 2024-04-29 | 2023-12-31 |
| Major company event | 8-K | 2024-04-23 | 2024-04-22 |
| S-3ASR | - | 2024-04-17 | - |
| SEC correspondence | UPLOAD | 2024-04-03 | - |
| Securities registration | S-3 | 2024-03-29 | - |
| Company correspondence | CORRESP | 2024-03-28 | - |
| Annual report | 10-K | 2024-03-19 | 2023-12-31 |
| Insider trade | 4 | 2024-02-26 | 2024-02-22 |
| Insider trade | 4 | 2024-02-26 | 2024-02-22 |
| Insider trade | 4 | 2024-02-26 | 2024-02-22 |
| Insider trade | 4 | 2024-02-26 | 2024-02-22 |
| Insider trade | 4 | 2024-02-26 | 2024-02-22 |
| Major company event | 8-K | 2024-02-26 | 2024-02-22 |
| Insider trade | 4 | 2024-02-06 | 2024-02-05 |
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Insider trade | 4 | 2024-02-02 | 2024-01-31 |
| Activist ownership stake (update) | SC 13D/A | 2024-01-04 | - |
| Insider trade | 4 | 2024-01-03 | 2023-12-29 |
| Insider trade | 4 | 2024-01-03 | 2023-12-31 |
| Insider trade | 4 | 2024-01-03 | 2023-12-31 |
| Major company event | 8-K | 2024-01-02 | 2023-12-29 |
| Insider trade | 4 | 2023-12-19 | 2023-12-15 |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| DEF 14C | - | 2023-09-28 | 2023-09-28 |
| D | - | 2023-09-22 | - |
| Activist ownership stake (update) | SC 13D/A | 2023-09-21 | - |
| PRE 14C | - | 2023-09-18 | 2023-09-15 |
| Insider trade | 4 | 2023-09-13 | 2023-09-11 |
| Major company event | 8-K | 2023-09-11 | 2023-09-11 |
| Insider trade | 4 | 2023-09-06 | 2023-09-01 |
| Insider trade | 4 | 2023-09-06 | 2023-09-01 |
| Insider trade | 4 | 2023-09-06 | 2023-09-01 |
| Major company event | 8-K | 2023-09-01 | 2023-08-31 |
| Insider trade | 4 | 2023-08-28 | 2023-08-25 |
| Insider trade | 4 | 2023-08-28 | 2023-08-25 |
| Insider trade | 4 | 2023-08-28 | 2023-08-25 |
| Major company event | 8-K | 2023-08-15 | 2023-08-14 |
| Quarterly report | 10-Q | 2023-08-08 | 2023-06-30 |
| Prospectus supplement | 424B5 | 2023-07-25 | - |
| Prospectus supplement | 424B5 | 2023-07-24 | - |